Skip Navigation LinksHome > March/April 2014 - Volume 25 - Issue 2 > The rapid evolution of cellular therapies for the treatment...
Current Orthopaedic Practice:
doi: 10.1097/BCO.0000000000000073
Review Articles

The rapid evolution of cellular therapies for the treatment of hip osteonecrosis

Homma, Yasuhiroa,b; Sand, Theodorec; Hernigou, Philippeb

Collapse Box


Hip osteonecrosis is a pathological condition resulting from cellular impairment from reductions in osteoblast activity and the local mesenchymal stem cell population. Cell-based therapies could correct such deficiencies by providing stem and other progenitor cells potentially to improve the local cellular environment in the affected hip. A rationale for the use of cytotherapy as well as a description of the technique of autologous bone marrow concentrate implantation are provided in the context of treating hip osteonecrosis. Current problems and future challenges with cytotherapy and associated techniques are discussed.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.